Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | ...

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

Selonterra, Inc. ( a biotechnology company developing transformative therapies for neurodegenerative disorders announces that ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.

Former Detroit Red Wings forward Mark Kirton, who enjoyed the most productive seasons of his NHL career with the franchise, has tragically lost his battle against ALS and passed away Sunday at just 67 ...

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...